Delivery Order SPE2DB24D1205-SPE2DB26FCQPY
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,330.68 for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $3,082.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector pharmaceutical product on August 25, 2025, with completion targeted for September 16, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively procured...
- The Defense Logistics Agency awarded a delivery order valued at $9,248.01 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on September 19, 2025, with an ultimate completion date of October 10, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Benlysta 200 mg/ml auto-injector pharmaceutical supplies. This $6,165.34 firm fixed price delivery order is scheduled for completion by September 3, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical product, valued at $9,975.58, with a firm fixed price structure. This delivery order, issued on May 6, 2025, is classified as a child contract under a larger vehicle and carries an ultimate completion date of May 28, 2025. The award represents a non-competitive delivery order executed under AmerisourceBergen's existing indefinite delivery contract framework...
- The Defense Logistics Agency awarded a delivery order valued at $9,248.01 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injectors. This firm fixed-price contract, awarded on July 28, 2025, with completion targeted for August 18, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $4,987.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/mL auto-injector pharmaceutical supplies. The contract, effective May 27, 2025, with completion targeted for June 17, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, non-set-aside contract with a completion date of September 25, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Benlysta 200 mg/mL auto-injector, valued at $6,165.34. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 12, 2025. The order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB26FCQPYDelivery Order
The Defense Logistics Agency awarded a $9,248.01 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector units. The contract, issued on October 16, 2025, with an ultimate completion date of November 6, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order was competitively awarded without set-aside designation, reflecting the vendor's demonstrated capability to meet federal pharmaceutical procurement requirements through open competition. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, maintaining a comprehensive portfolio of brand-name and generic medications across multiple therapeutic domains. The parent IDC with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, functions as a global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and specialized medical supplies to support military healthcare programs worldwide. This delivery order for Benlysta, a biologic treatment typically used for systemic lupus erythematosus, exemplifies the company's role in providing specialized pharmaceutical products to the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 10/16/25 |